Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
12 Junho 2024 - 5:20PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment
No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ |
Preliminary Proxy Statement |
| ☐ |
Confidential, for Use of the Commission Only as permitted by Rule
14a-6(e)(2)) |
| ☐ |
Definitive Proxy Statement |
| ☒ |
Definitive Additional Materials |
| ☐ |
Soliciting Material Pursuant to § 240.14a-12 |
STERIS plc
(Name of Registrant as Specified
in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☐ |
Fee paid previously with preliminary materials. |
| ☐ |
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
14a-6(i)(l) and 0-11. |
V51866-P14001-Z87797
You invested in
STERIS plc and it’s time to vote!
You have the right to vote on proposals being presented at the Annual General
Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on August 1, 2024.
Get informed before you vote
View the Notice and Proxy Statement, Fiscal 2024 Annual Report, and Directors’ Report and Consolidated Financial Statements
for the Year Ending March 31, 2024 online OR you can receive a free paper or email copy of the material by requesting prior to July 18, 2024. If you would like to request a copy of the material for this and/or future shareholder meetings, you may
(1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an
email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.
|
|
|
|
|
|
|
| Smartphone users |
|
|
|
|
|
Vote in Person at the Meeting*
August 1, 2024 9:00 a.m. Dublin
Time (4:00 am Eastern Daylight Saving Time) |
| Point your camera here and |
|
|
| vote without entering a |
|
|
| control number |
|
|
|
|
|
|
|
Meeting will be held at 70 Sir John Rogerson’s Quay Dublin 2, Ireland |
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
*Please check the meeting materials for any special requirements for meeting attendance and instructions on how to request directions to the
meeting. At the meeting, you will need to request a ballot to vote these shares.
Vote at www.ProxyVote.com
THIS IS NOT A VOTABLE BALLOT
This is an overview of the proposals being presented at the
upcoming shareholder meeting. Please follow the
instructions on
the reverse side to vote these important matters.
|
|
|
|
|
| Voting Items |
|
Board
Recommends |
|
|
|
| 1. Re-election of Directors |
|
|
|
|
|
|
|
| Nominees:
|
|
|
|
|
| 1a. Dr. Esther M. Alegria |
|
|
|
For |
|
|
|
| 1b. Richard C. Breeden |
|
|
|
For |
|
|
|
| 1c. Daniel A. Carestio |
|
|
|
For |
|
|
|
| 1d. Cynthia L. Feldmann |
|
|
|
For |
|
|
|
| 1e. Christopher S. Holland |
|
|
|
For |
|
|
|
| 1f. Dr. Jacqueline B. Kosecoff |
|
|
|
For |
|
|
|
| 1g. Paul E. Martin |
|
|
|
For |
|
|
|
| 1h. Dr. Nirav R. Shah |
|
|
|
For |
|
|
|
| 1i. Dr. Mohsen M. Sohi |
|
|
|
For |
|
|
|
| 1j. Dr. Richard M. Steeves |
|
|
|
For |
|
|
|
|
2. To ratify the appointment of
Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending March 31, 2025. |
|
|
|
For |
|
|
|
|
3. To appoint Ernst & Young Chartered
Accountants as the Company’s statutory auditor under Irish law to hold office until the conclusion of the Company’s next annual general meeting. |
|
|
|
For |
|
|
|
|
4. To authorize the Board of Directors of the
Company or the Audit Committee of the Board of Directors to determine the remuneration of Ernst & Young Chartered Accountants as the Company’s statutory auditor under Irish law. |
|
|
|
For |
|
|
|
|
5. To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation
discussion and analysis and the tabular and narrative disclosure contained in the Company’s proxy statement dated June 12, 2024. |
|
|
|
For |
|
|
|
|
6. To approve a proposal renewing the Board of
Director’s authority to issue shares under Irish law. |
|
|
|
For |
|
|
|
|
7. To approve a proposal renewing the Board of
Director’s authority to opt-out of statutory pre-emption rights under Irish law. |
|
|
|
For |
|
|
|
8. To transact such other business as may
properly come before the meeting or any adjournment or postponement
thereof. |
|
|
|
|
|
|
|
|
|
|
| Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. |
V51867-P14001-Z87797
STERIS (NYSE:STE)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
STERIS (NYSE:STE)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
